Taiwan Liposome Co. Ltd. (TLC), of Taipei, Taiwan, signed a collaboration agreement with Sandoz AG, an affiliate in the generics division of Novartis AG, of Basel, Switzerland, giving Sandoz responsibility for commercialization of Liposomal Amphotericin B in the European Union and the U.S.